Does This Canadian Tech Company Deserve a Place in Your Portfolio?

Tecsys Inc. (TSX:TCS) is a debt-free supply management technology company operating primarily in the healthcare sector that pays a small but growing dividend.

| More on:
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The search for companies with excellent balance sheets often leads to companies operating in the technology space these days. Often, this is due to the fact that technology companies operate with lower capital expenditure than that of traditional companies. As their businesses are less capital intensive and their operations have relatively low overhead, technology companies can generate significant amounts of free cash.

Tecsys Inc. (TSX:TCS) is one of these low debt technology companies at which it is worthwhile to take a look. The company has a significant amount of cash on its books and very little debt to speak of. It also hasn’t issued an excessive number of shares over time, so its shares are not being continuously diluted. The company not only has an excellent balance sheet, but also pays out a dividend of about 1.17% at today’s prices. The company has been slowly raising this dividend over time, maintaining a good payout ratio of approximately 50% of earnings over time.

Tecsys is primarily a provider of supply chain management solutions primarily for healthcare, although it also has relationships with companies in other industries as well, including Canon Inc. The company’s revenue increased 2% year-over-year as of Q4 2018. Its contractual bookings for its supply chain services rose 33%, which should have a positive impact on revenues and earnings going forward.

The biggest concern was the decrease in earnings, with earnings per share reduced from $0.39 a share in Q4 2017 to $0.13 in the same period of 2018. However, earnings were still positive, revenues were still increasing, and bookings are looking positive. At this point, investors will have to look to the upcoming earnings to determine whether this is a one-time blip or a continuing trend.

The biggest risk to software-based companies such as Tecsys is often not their balance sheet, but their ability to generate recurring revenue and build relationships with their customers. These companies need to provide services that are better than their competitors and retain long-term contracts so that their customers do not move on to another service provider. Other competitors such as Kinaxis Inc. (TSX:KXS) also compete in the space, so companies need to find a niche. Barriers to entry are relatively low, so software-based companies must be competitive.

Tecsys has thus far been able to build its customer base. According to its Q4 report, the company recently locked in one of the largest healthcare contracts in its history, and its increased bookings should continue to build its revenue stream. Additionally, the company’s dividend, while not large, is a bonus for shareholders. It also operates in the healthcare sector, which is a sector for which there will always be a need.

It is always wise to consider whether an investment is better than alternatives. The sector has a few comparable technology-based supply-management companies that also operate with very little debt, giving investors choice as to which to add to their portfolio. In the case of Tecsys, the company appears interesting and worth keeping an eye on, although there is no rush to immediately enter a position.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kris Knutson has no position in any of the stocks mentioned. Kinaxis is a recommendation of Stock Advisor Canada.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »